Treatment of pyoderma gangrenosum with granulocyte and monocyte adsorption apheresis

Therapeutic Apheresis and Dialysis

Volumn 9, Issue 4, 2005, Pages 292-296

  Kanekura, Takuro ^a   Kawahara, Koichi ^a   Maruyama, Ikuro ^a   Kanzaki, Tamotsu ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Granulocyte and monocyte adsorption apheresis; Mac 1; Neutrophil; Pyoderma gangrenosum

Indexed keywords

ADSORPTION; ADULT; AGED; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CYTAPHERESIS; ERYTHEMA; EXUDATE; GRANULOCYTE; HUMAN; LABORATORY TEST; MALE; MONOCYTE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PUSTULE; PYODERMA GANGRENOSUM; REGENERATION; SKIN ABSCESS; SKIN BIOPSY; SKIN ULCER;

EID: 29144453494     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2005.00284.x     Document Type: Article

References (16)

1. Callen JP. Pyoderma gangrenosum. Lancet 1998;351:581-5.
2. Saniabadi AR, Hanai H, Takeuchi K et al. Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes. Ther Apher Dial 2003;7:48-59.
3. Hiraishi K, Takeda Y, Shiobara N et al. Studies on the mechanisms of leukocyte adhesion to cellulose acetate beads: an in vitro model to assess the efficacy of cellulose acetate carrier-based granulocyte and monocyte adsorption apheresis. Ther Apher Dial 2003;7:334-40.
4. Sawada K, Ohnishi K, Kosaka T et al. Leukocytapheresis therapy with leukocyte removal filter for inflammatory bowel disease. J Gastroenterol 1995;30:124-7.
5. Shimoyama T, Sawada K, Hiwatashi N et al. Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apheresis 2001;16:1-9.
6. Hanai H, Watanabe F, Takeuchi K et al. Leukocyte adsorption apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study. Clin Gastroenterol Hepatol 2003;1:28-35.
7. Kanekura T, Maruyama I, Kanzaki T. Granulocyte and monocyte adsorption apheresis for pyoderma gangrenosum. J Am Acad Dermatol 2002;47:320-1.
8. Kanekura T, Yoshii N, Yonezawa T, Kawabata H, Saruwatari H, Kanzaki T. Treatment of pustular psoriasis with granulocyte and monocyte adsorption apheresis. J Am Acad Dermatol 2003;49:329-32.
9. Kanekura T, Kawabata H, Maruyama I, Kanzaki T. Treatment of psoriatic arthritis with granulocyte and monocyte adsorption apheresis. J Am Acad Dermatol 2004;50:242-6.
10. Kanekura T, Hashiguchi T, Mera Y et al. Improvement of SLE skin rash with granulocyte and monocyte adsorption apheresis. Dermatology 2004;208:79-80.
11. Kanekura T, Terasaki K, Higashi Y et al. Improvement of adult Still's disease with granulocyte and monocyte adsorption apheresis. Clin Exp Dermatol 2004;29:410-12.
12. Kanekura T, Gushi A, Iwata M et al. Treatment of Behcet's disease with granulocyte and monocyte adsorption apheresis. J Am Acad Dermatol 2004;51:S83-7.
13. Lee J, Hakim RM, Fearon DT. Increased expression of the C3b receptor by neutrophils and complement activation during haemodialysis. Clin Exp Immunol 1984;56:205-14.
14. Watanabe S, Ohara M, Takase Y, Ishida H, Kasukawa R. Modulation of adhesion molecules and carbohydrate antigens on granulocytes of patients with rheumatoid arthritis treated with granulo-monocytapheresis. Jpn J Rheumatol 1996;6:253-64.
15. Cai TQ, Wright SD. Human leukocyte elastase is an endogenous ligand for the integrin CR3 (CD11b/CD18, Mac-1, alpha M beta 2) and modulates polymorphonuclear leukocyte adhesion. J Exp Med 1996;184:1213-23.
16. Diamond MS, Springer TA. A subpopulation of Mac-;1 (CD11b:/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen. J Cell Biol 1993;120:545-56.